Skip to content
The Great News – Lifestyle
Home
Sample Page
Author:
Aer Therapeutics
Aer Therapeutics Announces Top-Line Results from its Phase 2a Proof-of-Concept Trial of Fexlamose in Chronic Obstructive Pulmonary Disease (“COPD”)
October 30, 2026